• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Electrophysiologic evaluation of antiarrhythmic drugs.

作者信息

Touboul P

机构信息

University of Lyon, Hôpital Cardiologique, France.

出版信息

Cardiovasc Drugs Ther. 1990 Jun;4 Suppl 3:535-9. doi: 10.1007/BF00357025.

DOI:10.1007/BF00357025
PMID:2275885
Abstract

Electrophysiologic techniques are used to assess the properties of antiarrhythmic drugs and also to provide support for the selection of antiarrhythmic therapy for individual patients. Assessment of the antiarrhythmic efficacy of drugs requires that the arrhythmia can be induced by programmed electrical stimulation and is critically dependent on the stimulation protocol. Continued inducibility on drug therapy appears to be a strong predictor of recurrences and sudden death, although the predictive value of electrophysiologic testing remains controversial for some drugs. These techniques may also be useful for determining the proarrhythmic potential of antiarrhythmic agents, but the aggravation of tachycardia that occurs in 10-30% of patients during electrophysiologic testing is unpredictable and its significance is unknown. The electrophysiologic approach to drug therapy has limitations, but, nevertheless, it is useful and should maintain a prominent place in the evaluation of antiarrhythmic therapy.

摘要

相似文献

1
Electrophysiologic evaluation of antiarrhythmic drugs.
Cardiovasc Drugs Ther. 1990 Jun;4 Suppl 3:535-9. doi: 10.1007/BF00357025.
2
Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
Am Heart J. 1985 Jul;110(1 Pt 1):9-16. doi: 10.1016/0002-8703(85)90507-1.
3
Cardiac electrophysiologic testing: its role in the selection of antiarrhythmic drug regimens for supraventricular and ventricular arrhythmias.
Pharmacotherapy. 1985 Mar-Apr;5(2):95-107. doi: 10.1002/j.1875-9114.1985.tb03408.x.
4
Proarrhythmic effects of antiarrhythmic drugs.
Med J Aust. 1990 Jul 2;153(1):37-47. doi: 10.5694/j.1326-5377.1990.tb125462.x.
5
Proarrhythmic responses during electrophysiologic testing.电生理检查期间的致心律失常反应。
Cardiol Clin. 1986 Aug;4(3):487-96.
6
Mode of action of antiarrhythmic drugs and the implicated arrhythmogenic risk.抗心律失常药物的作用机制及相关的致心律失常风险。
Eur Heart J. 1988 Feb;9 Suppl B:5-12. doi: 10.1093/eurheartj/9.suppl_b.5.
7
Proarrhythmic responses during electrophysiologic testing.电生理检查期间的致心律失常反应。
Am J Cardiol. 1987 Apr 30;59(11):45E-48E. doi: 10.1016/0002-9149(87)90201-3.
8
Can antiarrhythmic agents be selected based on mechanism of action?抗心律失常药物能否根据作用机制来选择?
Drugs. 2000 Dec;60(6):1315-28. doi: 10.2165/00003495-200060060-00006.
9
A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.七种抗心律失常药物治疗室性快速性心律失常患者的比较。电生理研究与心电图监测研究者。
N Engl J Med. 1993 Aug 12;329(7):452-8. doi: 10.1056/NEJM199308123290702.
10
[Proarrhythmic effects of anti-arrhythmia agents].[抗心律失常药物的促心律失常作用]
Rev Med Interne. 1995;16(8):602-7. doi: 10.1016/0248-8663(96)80759-4.

本文引用的文献

1
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Am J Cardiol. 1980 Oct;46(4):665-9. doi: 10.1016/0002-9149(80)90518-4.
2
Determinants of survival in patients with ventricular tachyarrhythmias.室性快速心律失常患者生存的决定因素。
N Engl J Med. 1983 Jun 16;308(24):1436-42. doi: 10.1056/NEJM198306163082402.
3
Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
Am Heart J. 1985 Jul;110(1 Pt 1):9-16. doi: 10.1016/0002-8703(85)90507-1.
4
Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: what is the significance of induced arrhythmias and what is the correct stimulation protocol?对有危及生命的室性心律失常患者进行心脏程控电刺激:诱发心律失常的意义是什么以及正确的刺激方案是什么?
Circulation. 1985 Jul;72(1):1-7. doi: 10.1161/01.cir.72.1.1.
5
The arrhythmogenicity of antiarrhythmic agents.抗心律失常药物的致心律失常性。
Am Heart J. 1985 May;109(5 Pt 1):1090-7. doi: 10.1016/0002-8703(85)90253-4.
6
Effects of intravenous sotalol in patients with atrioventricular accessory pathways.静脉注射索他洛尔对房室旁路患者的影响。
Am Heart J. 1987 Sep;114(3):545-50. doi: 10.1016/0002-8703(87)90751-4.
7
Pharmacologic therapy of ventricular tachycardia using electrophysiologic techniques.采用电生理技术的室性心动过速药物治疗
Cardiol Clin. 1986 Aug;4(3):473-86.
8
Electrophysiological action of bepridil on atrioventricular accessory pathways.苄普地尔对房室旁道的电生理作用。
Br Heart J. 1987 Oct;58(4):333-8. doi: 10.1136/hrt.58.4.333.